Assessment of student pharmacist‐led academic detailing on independent community pharmacy naloxone orders

Author:

Franko Thomas S.1ORCID,Yencha Bryce2,Sayre Jamie3

Affiliation:

1. Department of Pharmacy Practice, Nesbitt School of Pharmacy Wilkes University Wilkes‐Barre Pennsylvania USA

2. Nesbitt School of Pharmacy Wilkes University Wilkes‐Barre Pennsylvania USA

3. School of Pharmacy Wilkes University Wilkes‐Barre Pennsylvania USA

Abstract

AbstractIntroductionAcademic detailing has been used as a preferential method to increase pharmacists' awareness of naloxone; however, its impact on actual dispensing rates is not well established.ObjectiveThe aim of this pilot study is to determine if a student‐led academic detailing on naloxone use and communication increased the amount of naloxone ordered from independent pharmacies in various geographic settings throughout Northeast Pennsylvania.MethodsThirty‐nine independent pharmacies which utilized a single wholesaler were randomized to receive an in‐person, student‐led training about naloxone use and communication. Students attended a train‐the‐trainer presentation to ensure a universal training was provided to all pharmacies. Students were provided with intranasal naloxone demonstration devices, handouts on effective communication, and talking points for each pharmacy visit. All academic detailing sessions were held live at each pharmacy during that pharmacy's regular business hours. Topics covered included appropriate naloxone use, what to expect after giving naloxone, and evidence‐based communication methods for engaging with patients about purchasing naloxone. Devices and handouts were left behind for pharmacists to use in daily practice. Naloxone and opioid shipping data for 3 months prior to and 3 months post‐intervention were compared.ResultsNaloxone ordered in the pre‐intervention period was 21 vs. 26 (intervention vs. control) (p = 0.59) and 31 vs. 29 post‐intervention (p = 0.25). There was no statistically significant difference in the number of pharmacies which ordered more naloxone pre vs. post‐intervention or in the total amount of opioids ordered pre vs. post‐intervention.ConclusionWhile pharmacies which received academic detailing did order more naloxone than pharmacies which did not, the difference did not rise to a level of statistical significance. As the population of this pilot study was small, expanding this approach to academic detailing to a larger population is warranted to possibly see more robust results.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacy

Reference27 articles.

1. Centers for Disease Control and Prevention.U.S. overdose deaths in 2021 increased half as much as in 2020 – but are still up 15%. Published May 11 2022. [accessed 2023 Jun 28]. Available from:https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/202205.htm

2. Office of the Attorney General.Opioid Battle 2023 [accessed 2023 Jun 28]. Available from:https://www.attorneygeneral.gov/protect-yourself/opioid-battle/

3. Families Against Fentanyl.Fentanyl by age: Report. [accessed 2023 Jun 28]. Available from:https://www.familiesagainstfentanyl.org/research/byage

4. BullochM.As naloxone accessibility increases pharmacist's role expands. Pharm Times; 2016 [accessed 2023 Jun 28]. Available from:https://www.pharmacytimes.com/view/as‐naloxone‐accessibility‐increases‐pharmacists‐role‐expands

5. Office of the Surgeon General.U.S. Surgeon General's advisory on naloxone and opioid overdose. Reviewed 2022 Apr 8 2022 [accessed 2023 Jun 28]. Available from:https://www.hhs.gov/surgeongeneral/reports‐and‐publications/addiction‐and‐substance‐misuse/advisory‐on‐naloxone/index.html

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3